SCHEMBL2407969

SCHEMBL2407969

N=C(N)NCCC[C@H](NC(=O)[C@@H](N)CCCCN)C(=O)C(=O)CCl

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 11/20 0.45
▸ NPY1R P25929 6/20 0.45
▸ NPY2R P49146 4/20 0.45
▸ NPY5R Q15761 4/20 0.45
▸ GNAI3 P08754 1/20 0.43
▸ GNAO1 P09471 1/20 0.43
▸ GNAI1 P63096 1/20 0.43
▸ DPP7 Q9UHL4 3/20 0.41
▸ DPP8 Q6V1X1 2/20 0.41
▸ DPP9 Q86TI2 2/20 0.41
▸ SIRT6 Q8N6T7 1/20 0.38
▸ SIRT1 Q96EB6 1/20 0.38
▸ NOS1 P29475 1/20 0.37
▸ DPP4 P27487 1/20 0.36
▸ GSR P00390 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6680407 0.94 NPY4R (0.46) NPY4RNPY1RNPY2RNPY5RGNAI3
SCHEMBL4331923 0.92 NPY4R (0.44) NPY4RNPY1RNPY2RNPY5RGNAI3
SCHEMBL3516208 0.90 NPY4R (0.47) NPY4RNPY1RNPY2RNPY5RGNAI3
SCHEMBL31467756 0.86 NPY4R (0.53) NPY4RNPY1RNPY2RNPY5RGNAI3
SCHEMBL30017192 0.85 NPY4R (0.48) NPY4RNPY1RNPY2RNPY5RGNAI3
SCHEMBL30016402 0.85 NPY4R (0.48) NPY4RNPY1RNPY2RNPY5RGNAI3
SCHEMBL30528148 0.85 NPY4R (0.48) NPY4RNPY1RNPY2RNPY5RGNAI3
SCHEMBL6806494 0.85 NPY4R (0.48) NPY4RNPY1RNPY2RNPY5RGNAI3
SCHEMBL32932019 0.85 NPY4R (0.48) NPY4RNPY1RNPY2RNPY5RGNAI3
SCHEMBL288962 0.85 NPY4R (0.48) NPY4RNPY1RNPY2RNPY5RGNAI3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021202477-A1 SYSTEMS, METHODS, AND KITS FOR DIAGNOSTICS AND TREATMENT OF VIRAL RESPIRATORY INFECTION APPLIED BIOLOGY, INC. (US) 2021-10-07 — — WO claimed
EP-2538965-A1 THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE Schepens Eye Research Institute (US) 2013-01-02 — — EP disclosed
WO-2011106697-A1 THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF DRY EYE DISEASE SCHEPENS EYE RESEARCH INSTITUTE (US) 2011-09-01 — — WO disclosed
EP-1765375-A1 METHOD FOR INHIBITING ANGIOGENESIS AND/OR LYMPHANGIOGENESIS The Ludwig Institute for Cancer Research (US) 2007-03-28 — — EP disclosed
WO-2005112971-A1 METHOD FOR INHIBITING ANGIOGENESIS AND/OR LYMPHANGIOGENESIS LUDWIG INSTITUTE FOR CANCER RESEARCH (US) 2005-12-01 — — WO disclosed
Send feedback